CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands | Common Stock | Additional Paid-in Capital | Accumulated Deficit | Accumulated Other Comprehensive (Loss) Income | Total |
Balance at beginning of period at Dec. 31, 2020 | $ 235 | $ 154,866 | $ (62,927) | $ (1,200) | $ 90,974 |
Balance at beginning of period (in shares) at Dec. 31, 2020 | 23,526,517 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net loss | | | (5,228) | | (5,228) |
Unrealized income (loss) on foreign exchange rate translation | | | | 201 | 201 |
Stock-based compensation expense | | 101 | | | 101 |
Balance at end of period at Mar. 31, 2021 | $ 235 | 154,967 | (68,155) | (999) | 86,048 |
Balance at end of period (in shares) at Mar. 31, 2021 | 23,526,517 | | | | |
Balance at beginning of period at Dec. 31, 2020 | $ 235 | 154,866 | (62,927) | (1,200) | 90,974 |
Balance at beginning of period (in shares) at Dec. 31, 2020 | 23,526,517 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net loss | | | | | (22,110) |
Balance at end of period at Sep. 30, 2021 | $ 237 | 155,101 | (85,037) | (1,095) | 69,206 |
Balance at end of period (in shares) at Sep. 30, 2021 | 23,692,379 | | | | |
Balance at beginning of period at Mar. 31, 2021 | $ 235 | 154,967 | (68,155) | (999) | 86,048 |
Balance at beginning of period (in shares) at Mar. 31, 2021 | 23,526,517 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net loss | | | (9,017) | | (9,017) |
Unrealized income (loss) on foreign exchange rate translation | | | | 211 | 211 |
Issuance of common stock under stock compensation plans | $ 2 | (2) | | | |
Issuance of common stock under stock compensation plans (in shares) | 174,000 | | | | |
Stock-based compensation expense | | 67 | | | 67 |
Issuance of common stock as compensation | | 30 | | | 30 |
Issuance of common stock as compensation (in shares) | 11,320 | | | | |
Shares exchanged for taxes on stock-based compensation | | (75) | | | (75) |
Shares exchanged for taxes on stock-based compensation (in shares) | (31,410) | | | | |
Balance at end of period at Jun. 30, 2021 | $ 237 | 154,987 | (77,172) | (788) | 77,264 |
Balance at end of period (in shares) at Jun. 30, 2021 | 23,680,427 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net loss | | | (7,865) | | (7,865) |
Unrealized income (loss) on foreign exchange rate translation | | | | (307) | (307) |
Stock-based compensation expense | | 84 | | | 84 |
Issuance of common stock as compensation | | 30 | | | 30 |
Issuance of common stock as compensation (in shares) | 11,952 | | | | |
Balance at end of period at Sep. 30, 2021 | $ 237 | 155,101 | (85,037) | (1,095) | 69,206 |
Balance at end of period (in shares) at Sep. 30, 2021 | 23,692,379 | | | | |
Balance at beginning of period at Dec. 31, 2021 | $ 237 | 155,268 | (92,018) | (1,010) | $ 62,477 |
Balance at beginning of period (in shares) at Dec. 31, 2021 | 23,692,379 | | | | 23,643,934 |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net loss | | | (2,391) | | $ (2,391) |
Unrealized income (loss) on foreign exchange rate translation | | | | (233) | (233) |
Issuance of common stock under stock compensation plans | $ 1 | (1) | | | |
Issuance of common stock under stock compensation plans (in shares) | 155,000 | | | | |
Stock-based compensation expense | | 279 | | | 279 |
Treasury Stock Sale | | 113 | | | 113 |
Shares exchanged for taxes on stock-based compensation | | (79) | | | (79) |
Shares exchanged for taxes on stock-based compensation (in shares) | (35,050) | | | | |
Balance at end of period at Mar. 31, 2022 | $ 238 | 155,580 | (94,409) | (1,243) | 60,166 |
Balance at end of period (in shares) at Mar. 31, 2022 | 23,812,329 | | | | |
Balance at beginning of period at Dec. 31, 2021 | $ 237 | 155,268 | (92,018) | (1,010) | $ 62,477 |
Balance at beginning of period (in shares) at Dec. 31, 2021 | 23,692,379 | | | | 23,643,934 |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net loss | | | | | $ (17,672) |
Balance at end of period at Sep. 30, 2022 | $ 238 | 155,413 | (109,690) | (2,248) | $ 43,713 |
Balance at end of period (in shares) at Sep. 30, 2022 | 23,812,329 | | | | 23,812,329 |
Balance at beginning of period at Mar. 31, 2022 | $ 238 | 155,580 | (94,409) | (1,243) | $ 60,166 |
Balance at beginning of period (in shares) at Mar. 31, 2022 | 23,812,329 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net loss | | | (7,678) | | (7,678) |
Unrealized income (loss) on foreign exchange rate translation | | | | (439) | (439) |
Stock-based compensation expense | | 89 | | | 89 |
Balance at end of period at Jun. 30, 2022 | $ 238 | 155,669 | (102,087) | (1,682) | 52,138 |
Balance at end of period (in shares) at Jun. 30, 2022 | 23,812,329 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net loss | | | (7,603) | | (7,603) |
Cash settlement of RSUs | | (301) | | | (301) |
Unrealized income (loss) on foreign exchange rate translation | | | | (566) | (566) |
Stock-based compensation expense | | 45 | | | 45 |
Balance at end of period at Sep. 30, 2022 | $ 238 | $ 155,413 | $ (109,690) | $ (2,248) | $ 43,713 |
Balance at end of period (in shares) at Sep. 30, 2022 | 23,812,329 | | | | 23,812,329 |